£70 million Series A to advance Trogenix's 'potentially curative' cancer therapies into clinic

Retrieved on: 2025-10-06 14:41:17

Tags for this article:

Click the tags to see associated articles and topics

£70 million Series A to advance Trogenix's 'potentially curative' cancer therapies into clinic. View article details on hiswai:

Excerpt

6 October 2025. More on this story... Trogenix emerges from stealth with eyes on brain cancer · Biotechnology.

Article found on: www.thepharmaletter.com